UK markets open in 8 hours

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.32+0.31 (+1.29%)
At close: 04:00PM EDT
24.42 +0.10 (+0.41%)
After hours: 07:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.00B
Enterprise value 1.08B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.36
Price/book (mrq)2.19
Enterprise value/revenue 2.98
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.88
52-week change 3-23.76%
S&P500 52-week change 326.14%
52-week high 349.50
52-week low 316.95
50-day moving average 326.66
200-day moving average 326.65

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 3997.77k
Shares outstanding 582.31M
Implied shares outstanding 682.31M
Float 873.09M
% held by insiders 11.52%
% held by institutions 190.79%
Shares short (30 Apr 2024) 414.02M
Short ratio (30 Apr 2024) 48.64
Short % of float (30 Apr 2024) 422.31%
Short % of shares outstanding (30 Apr 2024) 417.03%
Shares short (prior month 28 Mar 2024) 413.45M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -37.33%
Operating margin (ttm)-1,405.29%

Management effectiveness

Return on assets (ttm)-8.44%
Return on equity (ttm)-16.09%

Income statement

Revenue (ttm)360.91M
Revenue per share (ttm)4.54
Quarterly revenue growth (yoy)-69.40%
Gross profit (ttm)N/A
EBITDA -160.89M
Net income avi to common (ttm)-134.74M
Diluted EPS (ttm)-1.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.09B
Total cash per share (mrq)13.87
Total debt (mrq)168.12M
Total debt/equity (mrq)18.40%
Current ratio (mrq)5.99
Book value per share (mrq)11.58

Cash flow statement

Operating cash flow (ttm)-139.13M
Levered free cash flow (ttm)-54.81M